Pharmafile Logo
Pharmafocus logo
Advanced Search

Carvolix strengthens its Board of Directors, advisory board and governance structure

April 23, 2026
Carvolix

Carvolix (formerly Affluent Medical) has announced it is strengthening its Board of Directors, advisory board and governance structure. As part …

Appointment

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

April 22, 2026
University of Huddersfield’s NHIC

Dr Zubir Ahmed MP, the Under-Secretary of State for Health Innovation and Safety, recently visited the newly opened Emily Siddon …

News

Incyclix Bio announces new additions to the Board

April 22, 2026
Incyclix Bio

Incyclix Bio has announced that it has raised $5m in additional funds for its Series B financing from new investor …

Appointment

Remedy Plan Therapeutics Appoints Jotin Marango as CFO and CBO

April 21, 2026
Remedy Plan Therapeutics

Remedy Plan Therapeutics has appointed Jotin Marango as Chief Financial and Business Officer (CFO & CBO). “Joti brings a strong …

Appointment

Xilio Therapeutics appoints Cheryl R Blanchard to Board

April 20, 2026
Xilio Therapeutics

Xilio Therapeutics has announced the appointment of Cheryl R Blanchard to the company’s board of directors. The company also announced …

Appointment

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026
Research and Development RWS, kayentis

Kayentis and RWS have announced a partnership aimed at improving confidence in clinical trial data for neuroscience and other complex …

News

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026
Research and Development

The Medicines and Healthcare products Regulatory Agency (MHRA) has secured new funding to expand its AI Airlock programme, aimed at …

News

Ardena opens new US bioanalytical laboratory

April 15, 2026
Business Services

Ardena has announced that its new GLP bioanalytical laboratory in Somerset, New Jersey in the US is operational and supporting …

News

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026
Research and Development Gesynta Pharma, endometriosis

Gesynta Pharma has dosed the first patient in its phase 2 clinical proof-of-concept trial of vipoglanstat. The trial, NOVA, is …

News

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026
Astellas Pharma, menopause

Final draft NICE guidance has recommended Veoza (fezolinetant), made by Astellas Pharma, to treat moderate to severe menopausal hot flushes …

News

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026
Ear Nose & throat

Sandoz has launched its azelastine and fluticasone fixed-dose-combination (FDC) nasal spray in Germany and Switzerland. In Germany the FDC over …

News

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026
Oncology

The Japan Pharmaceuticals and Medical Devices Agency (PMDA) has accepted the updated prescribing information for Daiichi Sankyo’s Enhertu (trastuzumab), a …

News

Trelleborg to take part in Medtec Japan 2026

April 8, 2026
Manufacturing and Production

Trelleborg Medical Solutions will showcase its latest engineered polymer solutions for demanding medical, biotech and pharmaceutical applications at Medtec Japan …

News

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026
Research and Development

Kainova Therapeutics has announced that the first patient in the European expansion of its DOMISOL phase I/II clinical trial evaluating …

News
drug-trials

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026
Research and Development

Eisai is to begin enrolling participants in its phase 2 study, Study 202, in patients with narcolepsy. The company registered …

News

Faron Pharmaceuticals appoints Heikki Jouttijärvi as Chief Technical Officer

April 2, 2026
Faron Pharmaceuticals

Faron Pharmaceuticals, a clinical-stage biopharmaceutical company, has appointed Heikki Jouttijärvi as Chief Technical Officer (CTO). Jouttijärvi brings decades of experience …

Appointment

Cambridge’s Grassroots Life Sciences Showcase Branches Out to Oxford & London

April 1, 2026
Conferencing, Events & Incentives Cambridge, Cambridge Wide Open Week, London, Oxford

Cambridge Wide Open Week (CWOW) returns from 11-19 June 2026, sharing the spirit and buzz of the week-long, interactive festival …

News

Doccla appoints Michael Macdonnell as Chief Strategy & Growth Officer and Deputy CEO

April 1, 2026
Doccla

Doccla, an AI-powered Proactive Care company, has appointed Michael Macdonnell as Chief Strategy & Growth Officer, and Deputy CEO. As …

Appointment

Bramacare launches new AI platform to improve eating disorder care

March 31, 2026
Market & Product Development AI, Bramacare, eating disorders

Bramacare has launched an AI-enabled platform designed to aid eating disorder and rehabilitation services, the first of its kind in …

News

Doccla appoints Jonathan Serjeant as Chief Medical Officer

March 31, 2026
Doccla

Doccla, an AI-powered Proactive Care company, has appointed Jonathan Serjeant as Chief Medical Officer (CMO). Serjeant brings 25 years of …

Appointment
The Gateway to Local Adoption Series

Latest content

Ofichem brings all brands under single trading name

April 23, 2026

Carvolix strengthens its Board of Directors, advisory board and governance structure

April 23, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

April 22, 2026

Incyclix Bio announces new additions to the Board

April 22, 2026

Remedy Plan Therapeutics Appoints Jotin Marango as CFO and CBO

April 21, 2026